• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER?; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER?; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952812250
Device Problem Occlusion Within Device (1423)
Patient Problems ST Segment Elevation (2059); Thrombosis (2100); Vomiting (2144); Discomfort (2330)
Event Date 12/29/2014
Event Type  Injury  
Event Description
Same case as mdr id 2134265-2015-00100.(b)(4) clinical study.It was reported that stent thrombosis occurred.In (b)(6) 2014, clinical assessment indicated that the patient's qualifying condition was stable angina.Subsequently, index procedure was performed.Target lesion #1 was located in the proximal circumflex (lcx) with 70% stenosis and was 18 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with pre-dilatation, placement of a 2.5 x 12 mm promus premier drug eluting stent and post-dilatation, with 0% residual stenosis.A second stent was attempted but was not implanted.Target lesion #2 was located in the distal circumflex with 80% stenosis and was 30 mm long with a reference vessel diameter of 2.5 mm.It was treated with pre-dilatation, placement of a 2.5 x 12 mm promus premier stent and post-dilatation, with 0% residual stenosis.A second stent was attempted but was not implanted.Post index procedure, the patient experienced an acute inferior myocardial infarction that was life-threatening requiring medical and surgical intervention; and prolonged hospitalization.Stent thrombosis was noted in the previously placed study stent located in the proximal lcx.In addition, a 10% stenosis in the proximal circumflex was treated with percutaneous coronary intervention (pci), atherectomy and placement of a drug eluting stent, with 0% residual stenosis.Two days post index procedure, the patient was discharged on protocol doses of aspirin and prasugrel.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that during the index procedure, target lesion #1 was located in the distal circumflex (lcx) which was treated with a 2.5 x 32 promus premier stent and not proximal lcx treated with (2.5 x 12mm promus premier) stent as previously reported.Also, target lesion #2 was located in the proximal lcx which was treated with a 2.5 x 20mm promus premier stent and not distal lcx treated (2.5 x 32mm promus premier⩠stent as previously reported.At the time of event, the patient developed chest discomfort and began vomiting.Patient's electrocardiogram indicated inferoposterior st-segment elevations corresponded to the recently placed stents in lcx.Repeat coronary angiography revealed a thrombotically occluded lcx.The physician performed manual aspiration thrombectomy to restored flow of the vessel.There was a substantial clot burden throughout the vessel and integrilin was administered in the coronary artery and peripherally.Balloon angioplasty was performed throughout the entirety of the previously stented segments followed by deployment of a 2.5 x 12 mm promus premier stent in the proximal lcx at the proximal end of the previously placed stent resulting in 0% residual stenosis.Post procedure, st segment changes on ecg and stent thrombosis were resolved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER?
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4441111
MDR Text Key20723243
Report Number2134265-2015-00099
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/23/2016
Device Model NumberH7493952812250
Device Catalogue Number39528-1225
Device Lot Number17319699
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/19/2015
Initial Date FDA Received01/22/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/09/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/13/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-